If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.00    0.00 (0.00%)
Bid:
11.50
Ask:
12.50
Spread: 1.00 (8.696%)
Market Cap: £15.02m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Acquisition

30 Apr 2007 07:03

Fabian Romania Property Fund Ltd30 April 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or the "Fund") Fabian Romania announces the purchase of a €60 million office building inBucharest Fabian Romania has reached agreement to purchase its fourth office project, theCubic office development (the "Cubic Centre"), in Bucharest. The Cubic Centrewill be a class A office building with a gross area of approximately 44,000square metres, located in North Bucharest. The building is being developed bythe Kendama, an experienced local developer in Romania. Construction hascommenced and completion is anticipated in the second quarter of 2009. The Cubic Centre will upon completion of construction provide a net lettableoffice area of 27,000 square metres over 12 floors, together with 533 carspaces. The building is located in a prominent location in the Pipera districtof North Bucharest and is likely to attract international tenants seeking classA office space. Vacancy rates for class A office space in in Bucharest are lessthan 3%. The acquisition is due to complete, subject to certain conditions, in twostages. The Fund will pay a first instalment of €12.25 million, of which €5million has already been paid in the form of a secured loan. At practicalcompletion of the building by the developer, the Fund will pay the finalinstalment based upon a forward purchase yield of 7.4% - 7.8% applied to rentsachieved. Based upon current rental estimates, the total value of thetransaction is estimated to be approximately of €60 million. The total equityrequirement for the fund is estimated to be €12 million. Commenting on the transaction, Mark Holdsworth, Managing Director of FabianCapital, the Investment Advisor to the Fund said: "We are delighted that the Fund has sealed its first investment since Admissionto AIM on favourable terms in what is a highly competitive market. The CubicCentre will provide a high quality addition to the Fund's portfolio of officebuildings. It will also give diversification geographically within the city bothin terms of building type and expected tenant mix." Mark Owen, Director responsible for acquisitions comments: "The new office development is in a prominent location in the rapidly expandingoffice location of the northern Pipera district of the City. This area will befurther enhanced by the new motorway link into the City. The Cubic Centre,which is already under construction on a fixed price basis, is well positionedto capitalise on the demand for Class A office space expected. We are already inearly discussions with a number of quality tenants seeking to upgrade theiroffice accommodation." The lead advisers on the transaction were Eurisko (property agent), WSP(technical advisers) and NNDKP (legal adviser). END For Comments:Fabian Romania:Mark Holdsworth +44 20 7499 9988 Nominated Adviser:Deloitte & Touche LLP +44 20 7936 3000James Lewis Broker:Shore Capital Stockbrokers LimitedDru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Aug 20197:00 amRNSPosting of Annual Report & Notice of AGM
3rd Jul 20194:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20197:00 amRNSFinal Results
29th Apr 20192:46 pmRNSDirector/PDMR Shareholding
25th Apr 20194:40 pmRNSSecond Price Monitoring Extn
25th Apr 20194:35 pmRNSPrice Monitoring Extension
18th Apr 20197:00 amRNSInvestor presentation
17th Apr 20197:00 amRNSTrading Update
25th Feb 20197:00 amRNSTrading Statement
21st Dec 20187:00 amRNSGrant of Options
17th Dec 20187:00 amRNSLaunch of Rational Affinity Maturation Platform
3rd Dec 20181:39 pmRNSDirector/PDMR Shareholding
26th Nov 20187:00 amRNSHalf-year Report
19th Nov 20187:00 amRNSNotice of Results
25th Sep 20182:23 pmRNSDirector/PDMR Shareholding
24th Sep 20184:13 pmRNSDirector/PDMR Shareholding
21st Sep 201811:24 amRNSResult of AGM
28th Aug 20187:00 amRNSPosting of Annual Report and Notice of AGM
16th Aug 20187:00 amRNSFinal Results
13th Aug 20187:00 amRNSTrading Update
20th Jun 20181:06 pmRNSOngoing discussions with MAB Discovery
24th May 20187:00 amRNSReceipt of additional grants from Invest NI
9th May 20183:40 pmRNSHolding(s) in Company
23rd Apr 201810:09 amRNSInvestor presentation
5th Mar 20187:00 amRNSTrading Statement
1st Mar 20187:00 amRNSReceipt of grants from Invest Northern Ireland
16th Jan 201810:06 amRNSDirector dealing
21st Dec 20179:35 amRNSHolding(s) in Company
21st Dec 20179:33 amRNSHolding(s) in Company
19th Dec 20177:00 amRNSHolding(s) in Company
19th Dec 20177:00 amRNSHolding(s) in Company
18th Dec 20178:00 amRNSAdmission to AIM and first day of dealings
10th Mar 20098:45 amRNSNotice of De-Listing
12th Feb 20093:37 pmRNSCompulsory Acqn of Shares
2nd Feb 20097:00 amRNSNet Asset Value(s)
29th Jan 20097:00 amRNSOffer Update
15th Jan 20097:00 amRNSOffer Update
9th Jan 20097:00 amRNSOffer Update
7th Jan 200911:55 amRNSRule 8.1- Fabian Romania Limited
24th Dec 200812:59 pmRNSOffer Document Posted
23rd Dec 20086:01 pmRNSRule 8.1- Fabian Romania Limited
22nd Dec 20084:16 pmBUSRule 8.3 - Fabian Romania Ltd.
22nd Dec 200810:46 amRNSRule 8.1- Fabian Romania Limited
19th Dec 20082:53 pmRNSCompulsory Acqn of Shares
19th Dec 20087:00 amRNSOffer for Fabian Romania Limited
5th Dec 20087:00 amRNSChange of Nominated Adviser's Name
11th Nov 20087:00 amRNSSite Update
10th Nov 200812:02 pmRNSHolding(s) in Company
7th Nov 20084:56 pmRNSHolding(s) in Company
4th Nov 200810:59 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.